PR and PartnershipONC's latest press release is impressive.
Unlike many of ONC's past PR's, this one is very clearly written and unambiguous.
It is also encouraging. And the promise comes from achievable honest milestones (very different from what we have seen in recent years).
The only outstanding question is financing. ONC does not currently have the funds.
I believe ONC is within weeks of announcing a major partnership. Three reasons for this:
1. The BC data are compelling enough for a major pharma to make a move.
2. Even with a reverse split and large capital raise, ONC will not be able to sufficiently finance a 180 patient tiral.
3. ONC is well aware they do not have the in house capabilities to proceed with a large registration enabling trial.
Best of luck. IMO This is an excellent entry point for any investor new to the story.